Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Environ Sci Pollut Res Int ; 31(23): 33708-33732, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38689044

RESUMO

The efficiency of iron/aluminum co-modified zeolite (FeAl-Z) covering and amendment for controlling the internal loading of phosphorus (P) from sediment to the overlying water (OW) and its controlling mechanism were explored. The response of the composition of sedimentary microbial communities in sediment and their function to the FeAl-Z capping and amendment was also examined. FeAl-Z showed good removal performance for phosphate in aqueous solution. The maximum phosphate adsorption quantity for FeAl-Z at pH 7 attained 11.2 mg P/g. The release of sediment endogenous phosphorus to OW can be successfully restrained by the FeAl-Z covering and amendment, and the suppression ability of FeAl-Z covering was stronger than that of FeAl-Z amendment. Under the capping or amendment condition, FeAl-Z can effectively inactivate the labile phosphorus measured by diffusion gradient in thin film (DGT-LP) in the overlying water and surface sediment. The added FeAl-Z transformed redox-sensitive phosphorus (BD-P) to metal oxide-bound phosphorus (NaOH-IP) and residual phosphorus (Res-P) in sediment, which increased the stability of inorganic phosphorus in the sediment. The passivation of soluble reactive phosphorus (SRP) and DGT-LP in the surface sediment by FeAl-Z significantly contributed to the inhibition of sediment endogenous phosphorus release to OW by the FeAl-Z capping, and the passivation of SRP, DGT-LP and mobile phosphorus in the surface sediment played a pivotal role in the control of sediment internal phosphorus release by the FeAl-Z amendment. The FeAl-Z amendment and capping did not increase the liberation risk of Fe from sediment, and the microorganisms in the sediments under the conditions of FeAl-Z amendment and covering still can perform good ecological functions. Results of this research demonstrate that FeAl-Z capping has high application potential in the control of phosphorus transfer from sediment to OW.


Assuntos
Alumínio , Sedimentos Geológicos , Ferro , Fósforo , Zeolitas , Zeolitas/química , Fósforo/química , Sedimentos Geológicos/química , Sedimentos Geológicos/microbiologia , Ferro/química , Alumínio/química , Adsorção , Poluentes Químicos da Água/química , Microbiota
2.
Chem Commun (Camb) ; 60(79): 11000-11016, 2024 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-39262314

RESUMO

Anion-exchange membrane water electrolysis (AEMWE) has attracted attention owing to its operation in alkaline environments, which offers the advantage of not requiring the use of precious metals. Additionally, AEMWE exhibits higher kinetics in the hydrogen evolution reaction, enabling higher hydrogen production efficiency. The anion-exchange membrane (AEM) fabrication, catalyst design, and membrane electrode assembly (MEA) are crucial for enhancing the total water electrolysis performance. There is an urgent need to summarize the advances in the development of AEMWE to pave the way for the commercialization of AEMWE. In this review, first, the fundamental principles of AEMWE technology are introduced. Second, the optimization of AEM with high ion conductivity and high stability through innovative synthetic methods are discussed in detail. Third, the designs of catalysts to increase the reaction rates by regulating the OH-adsorption environment and relieving OH blockage are introduced. Last but not least, a systematic summary of the concepts of 3D-ordered MEA, 3D-unified MEA, and 3D-self-supported MEA is presented. This review would be helpful to enhance the overall performance of AEMWE and promote the development of green hydrogen energy.

3.
Mil Med Res ; 11(1): 16, 2024 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-38462603

RESUMO

BACKGROUND: Episodic memory loss is a prominent clinical manifestation of Alzheimer's disease (AD), which is closely related to tau pathology and hippocampal impairment. Due to the heterogeneity of brain neurons, the specific roles of different brain neurons in terms of their sensitivity to tau accumulation and their contribution to AD-like social memory loss remain unclear. Therefore, further investigation is necessary. METHODS: We investigated the effects of AD-like tau pathology by Tandem mass tag proteomic and phosphoproteomic analysis, social behavioural tests, hippocampal electrophysiology, immunofluorescence staining and in vivo optical fibre recording of GCaMP6f and iGABASnFR. Additionally, we utilized optogenetics and administered ursolic acid (UA) via oral gavage to examine the effects of these agents on social memory in mice. RESULTS: The results of proteomic and phosphoproteomic analyses revealed the characteristics of ventral hippocampal CA1 (vCA1) under both physiological conditions and AD-like tau pathology. As tau progressively accumulated, vCA1, especially its excitatory and parvalbumin (PV) neurons, were fully filled with mislocated and phosphorylated tau (p-Tau). This finding was not observed for dorsal hippocampal CA1 (dCA1). The overexpression of human tau (hTau) in excitatory and PV neurons mimicked AD-like tau accumulation, significantly inhibited neuronal excitability and suppressed distinct discrimination-associated firings of these neurons within vCA1. Photoactivating excitatory and PV neurons in vCA1 at specific rhythms and time windows efficiently ameliorated tau-impaired social memory. Notably, 1 month of UA administration efficiently decreased tau accumulation via autophagy in a transcription factor EB (TFEB)-dependent manner and restored the vCA1 microcircuit to ameliorate tau-impaired social memory. CONCLUSION: This study elucidated distinct protein and phosphoprotein networks between dCA1 and vCA1 and highlighted the susceptibility of the vCA1 microcircuit to AD-like tau accumulation. Notably, our novel findings regarding the efficacy of UA in reducing tau load and targeting the vCA1 microcircuit may provide a promising strategy for treating AD in the future.


Assuntos
Doença de Alzheimer , Humanos , Masculino , Camundongos , Animais , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Camundongos Transgênicos , Proteômica , Hipocampo/metabolismo , Hipocampo/patologia , Transtornos da Memória/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa